Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chad Parkes

Orthopaedic Surgery Cary, NC Medical Doctor

NPI 1467973131 CMS profile 4695085

1120 Se Cary Pkwy Ste 100, Cary, NC 27518

Open in the dashboard

General payments

$23,873

173 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chad Parkes of Cary, NC is reported in the CMS Open Payments database as having received $23,873 across 173 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $798 15
2024 General $2,415 33
2023 General $7,164 47
2022 General $9,681 35
2021 General $1,492 14
2020 General $411 6
2019 General $1,911 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chad Parkes
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Chad Parkes were reported at $798. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Chad Parkes Orthopaedic Surgery median Middle half National median
2019 $1,911 $644 $140–$2,844 $163
2020 $411 $312 $75–$1,860 $114
2021 $1,492 $520 $117–$2,495 $132
2022 $9,681 $598 $128–$2,731 $149
2023 $7,164 $461 $128–$2,264 $160
2024 $2,415 $497 $134–$2,475 $164
2025 $798 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $6,034 56 payments
  2. Arthrex, Inc. $5,758 53 payments
  3. Smith+Nephew, Inc. $5,337 8 payments
  4. Encore Medical, LP $1,840 9 payments
  5. Tricoast Surgical Solutions LLC $1,806 21 payments
  6. Active Medical, LLC $1,200 1 payment
  7. Zimmer Biomet Holdings, Inc. $1,083 11 payments
  8. DePuy Synthes Sales Inc. $286 4 payments
  9. Bioventus LLC $216 3 payments
  10. Foundation Medical, LLC $125 1 payment
  11. Other $189 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $8,903 31 payments
  2. Food and Beverage $7,570 138 payments
  3. Education $7,400 4 payments
Products named General payments · program years 2019–2025
  1. GAMMA Trauma & Extremeties $1,542 12 payments
  2. SALVATION $1,252 5 payments
  3. DJO SURGICAL Joint Implants $1,030 8 payments
  4. DJO SURGICAL Joint Implants $810 1 payment
  5. ADAPT Hips $751 7 payments
  6. DVR Crosslock Plates/Screws/Pegs $697 7 payments
  7. ADAPT Hips $586 10 payments
  8. GAMMA Trauma & Extremeties $386 4 payments
  9. PRIME SERIES $312 2 payments
  10. Coblation $209 2 payments
  11. Other $3,109 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

138

Median for Orthopedic Surgery: 203

Drug cost

$661

Median for Orthopedic Surgery: $1,433

Branded share of claims

10.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 12 $172
Pregabalin Generic 14 $135
Oxycodone Hcl Generic 29 $121
Methylprednisolone Generic 22 $109
Meloxicam Generic 47 $66
Ondansetron Odt Ondansetron Brand 14 $58

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$44,414

Of which drugs: $2,682

Medicare patients

157

Average age 73

Services billed

988

98 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 67%
Diabetes 24%
Ischemic heart disease 23%
Chronic kidney disease 20%
Depression 20%
Osteoporosis 19%
Atrial fibrillation 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 45 284 $214

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

173 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record